HLA-DR2 predicts a favorable response to cyclosporine therapy in patients with bone marrow failure
- 1 July 1992
- journal article
- letter
- Published by Wiley in American Journal of Hematology
- Vol. 40 (3) , 239-240
- https://doi.org/10.1002/ajh.2830400319
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- DOES HLA-DR PREDICT RESPONSE TO SPECIFIC IMMUNOSUPPRESSIVE THERAPY IN APLASTIC ANAEMIA?British Journal of Haematology, 1990
- Cyclosporine therapy of aplastic anaemia, congenital and acquired red cell aplasiaBritish Journal of Haematology, 1989
- The Relation Between Major Histocompatibility Complex (MHC) Restriction and the Capacity of Ia to Bind Immunogenic PeptidesScience, 1987
- Increased frequency of DR2 in patients with aplastic anaemia and increased DR sharing in their parentsBritish Journal of Haematology, 1986
- B-Lymphocyte Alloantigens Associated with Systemic Lupus ErythematosusNew England Journal of Medicine, 1978
- STRONG ASSOCIATION BETWEEN HLA-DRW2 AND ANTIBODY-MEDIATED GOODPASTURE'S SYNDROMEThe Lancet, 1978